Why GSK plc’s (GSK) Stock Is Up 6.56%
As of Tuesday, July 28, GSK plc’s GSK share price has surged by 6.56%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Cynthia McLaughlin
Jenna Brashear
Cynthia McLaughlin
Jenna Brashear
| Share Statistics | GSK | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $101,986.2 | $433.9 | 97% |
|
| Shares Out (Mil) | 5,407.4 | 46.5 | 99% |
|
| Institutional Ownership | 99.9% | 82.2% | 96% |
|
| Float (Mil) | 3,885.4 | 47.7 | 97% |
|
| Beta | 0.28 | 0.74 | 15% |
|
| Avg Daily Volume (000s) | 3,151 | 345 | 86% |
|
| Price Change (52-week) |
4.7% | 52.0% | 55% |
|
| Growth | GSK | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.7% | 6.4% | 40% |
|
| Net Income (5yr) | (0.4%) | (1.6%) | 39% |
|
| EPS (5yr) | (0.8%) | 15.1% | 30 |
|
| Dividends (5yr) | (8.2%) | 0.0% | 77% |
|
| Cash Flow (5yr) | (19.7%) | (15.1%) | 34% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 4 | 5 | |
| Current EPS | $0.737 | $4.761 | $4.958 | |
| Month Ago EPS | $0.774 | $4.709 | $4.917 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $0.828 | $4.753 | $5.139 | |
| Year/Year Chg | 46.5% | 154.9% | 173.0% | |
| Financials | GSK | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $44,532 | $289 | 96% |
|
| Net Income (TTM) (Mil) | $5,777 | ($11) | 97% |
|
| EPS (TTM) | $1.438 | ($0.600) | 65% |
|
| Operating Cash Flow (TTM) (Mil) | $11,840 | ($7) | 98% |
|
| Net Cash Flow (TTM) (Mil) | ($152) | $1 | 12% |
|
| Long-Term Debt (Q1) (Mil) | $28,943 | $6 | 97% |
|
| Enterprise Value (Q1) (Mil) | $128,883 | $331 | 97% |
|
| Valuation | GSK | Industry Median |
Percentile (All Stocks) |
|
| P/B | 8.12 | 2.05 | 89% |
|
| P/E | 35.6 | 24.3 | 78% |
|
| Dividend Yield | 3.6% | 0.0% | 88% |
|
| PEG (5yr hist) | 14.2 | 1.2 | 96% |
|
| Ratios | GSK | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 73.8% | 69.5% | 84% |
|
| Net Margin | 13.0% | 3.9% | 69% |
|
| ROA | 6.5% | (23.3%) | 77% |
|
| ROE | 24.8% | (21.8%) | 84% |
|
| Liabilities to Assets | 74.4% | 31.2% | 70% |
|
| F-Score | 6 | 3 | 67% |
|
GSK plc did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors